SCHEMBL13298562

SCHEMBL13298562

c1ccc([SiH2]c2ccc3c(-c4cccc5ccccc45)c4ccccc4c(-c4cccc(-c5cc6ccccc6c6ccccc56)c4)c3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 1/20 0.36
▸ CYP11B1 P15538 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MPI P34949 1/20 0.35
▸ TSHR P16473 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ GPR84 Q9NQS5 2/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ MCL1 Q07820 1/20 0.32
▸ ACMSD Q8TDX5 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298559 1.00 SOS1 (0.36) SOS1CYP11B1ALDH1A1HPGDKDM4E
SCHEMBL13298551 0.95 SOS1 (0.36) SOS1CYP11B1ALDH1A1HPGDKDM4E
SCHEMBL13298547 0.95 SOS1 (0.36) SOS1CYP11B1ALDH1A1HPGDKDM4E
SCHEMBL13298542 0.93 MCL1 (0.37) SOS1ALDH1A1HPGDKDM4EMAPT
SCHEMBL13298545 0.93 MCL1 (0.37) SOS1ALDH1A1HPGDKDM4EMAPT
SCHEMBL13298519 0.92 SOS1 (0.37) SOS1CYP11B1ALDH1A1HPGDKDM4E
SCHEMBL13298521 0.92 SOS1 (0.37) SOS1CYP11B1ALDH1A1HPGDKDM4E
SCHEMBL13298533 0.90 CA12 (0.36) SOS1ALDH1A1HPGDKDM4EMAPT
SCHEMBL13298539 0.90 CA12 (0.36) SOS1ALDH1A1HPGDKDM4EMAPT
SCHEMBL13298586 0.89 SOS1 (0.37) SOS1CYP11B1ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 SOS1 2366/4885CYP11B1 2489/4885ALDH1A1 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback